Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF) Short Interest Up 13.7% in October

Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXFGet Free Report) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 5,800 shares, a growth of 13.7% from the October 15th total of 5,100 shares. Based on an average daily trading volume, of 1,400 shares, the days-to-cover ratio is presently 4.1 days.

Wall Street Analysts Forecast Growth

Separately, Raymond James boosted their price target on shares of Eupraxia Pharmaceuticals from C$17.00 to C$18.00 in a research note on Monday, September 25th.

Check Out Our Latest Research Report on EPRXF

Eupraxia Pharmaceuticals Price Performance

Shares of OTCMKTS:EPRXF opened at C$3.96 on Friday. Eupraxia Pharmaceuticals has a 12 month low of C$2.66 and a 12 month high of C$6.78. The company has a 50-day moving average price of C$4.84 and a 200-day moving average price of C$5.28.

About Eupraxia Pharmaceuticals

(Get Free Report)

Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.

Featured Stories

Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with's FREE daily email newsletter.